BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6203189)

  • 41. [Personal experiences with methotrexate in tumor therapy].
    Greiner GF; Dillenschneider E
    Monatsschr Ohrenheilkd Laryngorhinol; 1966 Oct; 100(10):447-9; discussion 449. PubMed ID: 16114441
    [No Abstract]   [Full Text] [Related]  

  • 42. [Recurrence of lung cancer--its treatment and prevention].
    Yamaguchi Y
    Gan No Rinsho; 1983 Aug; 29(10):1063-71. PubMed ID: 6632192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of treatment results for floor-of-mouth cancer.
    Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recent findings in the field of oncological therapy with interferon].
    Pugliese A; Vitale M; Cosseta P
    G Batteriol Virol Immunol; 1981; 74(7-12):308-19. PubMed ID: 6182049
    [No Abstract]   [Full Text] [Related]  

  • 47. [Recurrence of nasopharyngeal fibroma. Study of 21 recurrences of 49 nasopharyngeal fibromas].
    Sergent H; Muler H
    Probl Actuels Otorhinolaryngol; 1968; ():201-8. PubMed ID: 5758449
    [No Abstract]   [Full Text] [Related]  

  • 48. [Intra-arterial regional chemotherapy in the overall treatment of nasopharyngeal tumors].
    Baibakov AB; Liubchak AA
    Zh Ushn Nos Gorl Bolezn; 1974; (3):97-8. PubMed ID: 4446786
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacological aspects of clinical stage I/II trials with human beta interferon in children.
    Treuner J; Dannecker G; Joester KE; Hettinger A; Niethammer D
    J Interferon Res; 1981; 1(3):373-80. PubMed ID: 6180069
    [No Abstract]   [Full Text] [Related]  

  • 50. [On classification and stage division of malignant tumors of the nasopharyngeal region].
    Krüger H; Schöder HJ; Kressin J
    HNO; 1967 Nov; 15(11):328-9. PubMed ID: 5596446
    [No Abstract]   [Full Text] [Related]  

  • 51. Interferon: IFs and buts of cancer treatment.
    Iveson-Iveson J
    Nurs Mirror; 1980 Jul; 151(5):34-6. PubMed ID: 6157150
    [No Abstract]   [Full Text] [Related]  

  • 52. Interferon combinations in cancer therapy.
    Itri LM
    Cancer Invest; 1990; 8(2):305-6. PubMed ID: 1698113
    [No Abstract]   [Full Text] [Related]  

  • 53. Interferon to fight cancer.
    Roy S
    J Indian Med Assoc; 1980 Oct; 75(7):147-8. PubMed ID: 6165778
    [No Abstract]   [Full Text] [Related]  

  • 54. [An attempt to treat milker's nodules by using interferon (author's transl)].
    Puntarić V; Borcić D; Scetinec N; Taborsky V; Cvetnić S
    Lijec Vjesn; 1980 Feb; 102(3):137-8. PubMed ID: 6157068
    [No Abstract]   [Full Text] [Related]  

  • 55. 24-gene predictor of response to postoperative irradiation.
    Bolla M
    Lancet Oncol; 2016 Nov; 17(11):1478-1480. PubMed ID: 27743921
    [No Abstract]   [Full Text] [Related]  

  • 56. [Not Available].
    Rudack C
    Laryngorhinootologie; 2020 Jan; 99(1):8-9. PubMed ID: 31935752
    [No Abstract]   [Full Text] [Related]  

  • 57. UCNT: chemocurable sometimes, but not very often.
    Cvitkovic E
    Ann Oncol; 1997 Aug; 8(8):723-5. PubMed ID: 9332678
    [No Abstract]   [Full Text] [Related]  

  • 58. Nodal interferon exposure drives tumour-specific tolerance.
    Barranco C
    Nat Rev Cancer; 2022 Jul; 22(7):377. PubMed ID: 35668152
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of nasopharyngeal cancer with interferon].
    Treuner J; Niethammer D
    Strahlentherapie Sonderb; 1984; 78():184-7. PubMed ID: 6203189
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current experiences with interferon therapy in 7 patients with nasopharyngeal cancer].
    Mertens R; Karstens JH; Ammon J; Classen HW; Mittermayer C
    Strahlentherapie Sonderb; 1984; 78():188-93. PubMed ID: 6203190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.